1. Home
  2. PSNL vs NXRT Comparison

PSNL vs NXRT Comparison

Compare PSNL & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • NXRT
  • Stock Information
  • Founded
  • PSNL 2011
  • NXRT 2014
  • Country
  • PSNL United States
  • NXRT United States
  • Employees
  • PSNL N/A
  • NXRT N/A
  • Industry
  • PSNL Medical Specialities
  • NXRT Real Estate Investment Trusts
  • Sector
  • PSNL Health Care
  • NXRT Real Estate
  • Exchange
  • PSNL Nasdaq
  • NXRT Nasdaq
  • Market Cap
  • PSNL 854.8M
  • NXRT 776.2M
  • IPO Year
  • PSNL 2019
  • NXRT N/A
  • Fundamental
  • Price
  • PSNL $7.79
  • NXRT $30.83
  • Analyst Decision
  • PSNL Strong Buy
  • NXRT Hold
  • Analyst Count
  • PSNL 7
  • NXRT 5
  • Target Price
  • PSNL $10.43
  • NXRT $36.33
  • AVG Volume (30 Days)
  • PSNL 1.5M
  • NXRT 132.1K
  • Earning Date
  • PSNL 11-04-2025
  • NXRT 10-28-2025
  • Dividend Yield
  • PSNL N/A
  • NXRT 6.85%
  • EPS Growth
  • PSNL N/A
  • NXRT N/A
  • EPS
  • PSNL N/A
  • NXRT N/A
  • Revenue
  • PSNL $69,103,000.00
  • NXRT $253,196,000.00
  • Revenue This Year
  • PSNL N/A
  • NXRT N/A
  • Revenue Next Year
  • PSNL $29.83
  • NXRT $2.95
  • P/E Ratio
  • PSNL N/A
  • NXRT N/A
  • Revenue Growth
  • PSNL N/A
  • NXRT N/A
  • 52 Week Low
  • PSNL $2.83
  • NXRT $29.93
  • 52 Week High
  • PSNL $10.95
  • NXRT $48.31
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 46.21
  • NXRT 46.27
  • Support Level
  • PSNL $6.63
  • NXRT $30.62
  • Resistance Level
  • PSNL $9.89
  • NXRT $31.67
  • Average True Range (ATR)
  • PSNL 0.80
  • NXRT 0.69
  • MACD
  • PSNL -0.21
  • NXRT 0.04
  • Stochastic Oscillator
  • PSNL 32.79
  • NXRT 33.62

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

Share on Social Networks: